OBJECTIVE: To assess the feasibility of introducing into the UK's NHS a national screening programme for colorectal cancer based on faecal occult blood testing. DESIGN: Demonstration pilot. SETTING: Two English health authorities and three Scottish health boards. PARTICIPANTS: People aged 50-69 years. RESULTS: 478,250 residents of the pilot areas were invited to take part in the screening programme. Uptake (the proportion in whom a final faecal occult blood test result was available) was 56.8% (n = 271,646). The overall rate of a positive test result was 1.9% and the rate for detecting cancer was 1.62 per 1000 people screened. Both these values were higher in Scotland than in England, higher in men than in women, and increased with age. The positive predictive value was 10.9% for cancer and 35.0% for adenoma. 552 cancers were detected by screening; 92 (16.6%) were polyp cancers. 48% of all screen detected cancers were Dukes's stage A, and 1% had metastasised at the time of diagnosis. CONCLUSIONS: Screening for colorectal cancer by testing for faecal occult blood is feasible within the context of the United Kingdom's NHS. Screening should lead to a reduction in deaths from colorectal cancer in the population offered screening.
OBJECTIVE: To assess the feasibility of introducing into the UK's NHS a national screening programme for colorectal cancer based on faecal occult blood testing. DESIGN: Demonstration pilot. SETTING: Two English health authorities and three Scottish health boards. PARTICIPANTS: People aged 50-69 years. RESULTS: 478,250 residents of the pilot areas were invited to take part in the screening programme. Uptake (the proportion in whom a final faecal occult blood test result was available) was 56.8% (n = 271,646). The overall rate of a positive test result was 1.9% and the rate for detecting cancer was 1.62 per 1000 people screened. Both these values were higher in Scotland than in England, higher in men than in women, and increased with age. The positive predictive value was 10.9% for cancer and 35.0% for adenoma. 552 cancers were detected by screening; 92 (16.6%) were polyp cancers. 48% of all screen detected cancers were Dukes's stage A, and 1% had metastasised at the time of diagnosis. CONCLUSIONS: Screening for colorectal cancer by testing for faecal occult blood is feasible within the context of the United Kingdom's NHS. Screening should lead to a reduction in deaths from colorectal cancer in the population offered screening.
Authors: R J Steele; R Parker; J Patnick; J Warner; C Fraser; N A Mowat; J Wilson; F E Alexander; J G Paterson Journal: J Med Screen Date: 2001 Impact factor: 2.136
Authors: R J Steele; R Gnauck; R Hrcka; O Kronborg; C Kuntz; P Moayyedi; C O'Morain; J Spicák; H Vainio Journal: Endoscopy Date: 2004-04 Impact factor: 10.093
Authors: Grace Clarke Hillyer; Benjamin Lebwohl; Richard M Rosenberg; Alfred I Neugut; Randi Wolf; Corey H Basch; Jennie Mata; Edwin Hernandez; Douglas A Corley; Steven Shea; Charles E Basch Journal: Therap Adv Gastroenterol Date: 2014-11 Impact factor: 4.409
Authors: Jill Tinmouth; Paul Ritvo; S Elizabeth McGregor; Jigisha Patel; Crissa Guglietti; Cheryl A Levitt; Lawrence F Paszat; Linda Rabeneck Journal: Can Fam Physician Date: 2013-12 Impact factor: 3.275
Authors: W S A Smellie; K K Hampton; R Bowley; R Bowlees; S C Martin; N Shaw; J Hoffman; J P Ng; S M Mackenzie; C van Heyningen Journal: J Clin Pathol Date: 2006-12-15 Impact factor: 3.411
Authors: J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams Journal: Gut Date: 2007-02 Impact factor: 23.059
Authors: Germaine Wong; Kirsten Howard; Jeremy R Chapman; Allison Tong; Michael J Bourke; Andrew Hayen; Petra Macaskill; Richard L Hope; Narelle Williams; Anh Kieu; Richard Allen; Steven Chadban; Carol Pollock; Angela Webster; Simon D Roger; Jonathan C Craig Journal: BMC Public Health Date: 2011-06-29 Impact factor: 3.295